MINDRAY, China's largest medical device company, returned A shares
Recently, the vice president of Chinese Medical Device Industry Association unit of Shenzhen MINDRAY Bio Medical Electronic Limited by Share Ltd (hereinafter referred to as “ MINDRAY medical ”) on the SFC website disclosure of the prospectus, to be in the Shenzhen Stock Exchange public offering of not more than 121 million 600 thousand shares, plans to raise 6 billion 626 million yuan of funds.
MINDRAY medical was founded in 1991, and landed on the New York stock exchange in 2006. After the privatization delisting in March 2016, the IPO process of the giant medical device enterprises was affecting the market nerves at all times.
Prospectus disclosed MINDRAY medical nearly 3 years of production data, roughly arranged as follows.
Medical MINDRAY 2016 operating income was 9 billion 32 million yuan, more than Xinhua medical (8 billion 364 million yuan) and Weigao (6 billion 730 million yuan), and become the largest China medical equipment manufacturing enterprises
MINDRAY healthcare is headquartered in Shenzhen China, more than in North America, Europe, Asia, Africa, Latin America and other regions with 39 subsidiaries in 30 countries; in the country with 18 subsidiaries, more than 40 branches, forming a huge global R & D, marketing and service network. Its products, sales and solutions have been used in more than 190 countries and regions worldwide. 2014-2016 years, MINDRAY medical revenues were 7 billion 836 million yuan, 8 billion 13 million yuan, 9 billion 32 million yuan, steadily increasing year by year (Figure 2). In 2016, MINDRAY medical international market sales accounted for 50% of revenue.
MINDRAY medical roots in the field of medical devices, go endogenous and epitaxial development both on the road and continue to expand the product line and the region, experienced from single product to multi product line, from the domestic market into the global market, the development of low-end products extends to high-end products. At present, MINDRAY products are mainly concentrated in the three major areas of medical devices: life information and support, in vitro diagnostics and medical imaging. In addition, in the past few years, MINDRAY medical has expanded the product line through a series of mergers and acquisitions, including Department of orthopedics, endoscopes and other high-value consumables field. 2014-2016, life information and support, and in vitro diagnostic medical imaging three products together accounted for the proportion of main business income was 97.65%, 97.65%, 97.86% (Figure 3); the main business gross profit margin was 63.42%, 62.22%, 64.62%, the overall relatively stable.